Abstract：Objective: To implement clinical analysis of reoperation in 94 cases of patients with thyroid carcinoma in our hospital, and to provide a theoretical basis for the choice of mode and timing of reoperation. Methods: This study included 94 cases of reoperated patients with thyroid carcinoma in our hospital from June 2013 -June 2015, the medical records of 94 cases were retrospectively analyzed, and paraffin section diagnosis was taken again, the first operation mode, time of first operation to reoperation, reoperation causes and reoperation mode were recorded, through 2 years of follow up, prognosis after reoperation was observed. Results: There were 12 cases of reoperation at recent period (2~30d) of the first operation , the proportion was 12.77%, mid term (31d~1y) had 40 cases, the proportion was 42.55%, later period (＞1y) had 42 cases, the proportion was 44.68%; There were 78 cases showed causes of reoperation were recurrence and lymph node metastasis, the proportion was 82.98%, residual tumor after first operation had 16 cases, the proportion was 17.02%; The second pathological diagnosis showed thyroid papillary carcinoma of 80 cases, the ratio was 85.11%, 8 cases of medullary carcinoma, the ratio was 8.51%, 6 cases of follicular carcinoma, the proportion was 6.38%; Reoperation mode were 37 cases of total thyroidectomy, 33 cases of unilateral lobe and isthmus resection, 16 cases of unilateral lobe, isthmus, and contralateral subtotal resection, 4 cases of simple selective lymph node dissection, 4 cases of radical thyroidectomy and total laryngectomy; Two years of follow-up after operation, 2 cases of death due to multiple lung metastasis, 1 case of partial recurrence death due to suffocation, the rest were tumor-free survival. Conclusion: Partial recurrence, lymph node metastasis, residual tumor after surgery are major causes of reoperations in patients with thyroid carcinoma, pathological diagnosis are mainly thyroid papillary carcinoma, surgery mode of reoperation shall be based on color ultrasound, CT, FNAC examination.
施杲旸, 陆辉, 王莹. 94例甲状腺癌患者再手术治疗的临床分析[J]. 河北医学, 2017, 23(10): 1718-1721.
SHI Gaoyang, LU Hui, WANG Ying. Clinical Analysis of Reoperation in 94 Cases of Patients with Thyroid Carcinoma. 河北医学, 2017, 23(10): 1718-1721.
[1]胡尔维,姜训圳,刘立彬,等.全甲状腺切除术治疗甲状腺癌的临床分析[J].实用肿瘤杂志,2014,29(1):69~72. [2] 赵志刚,彭亮,李亚军,等.(131)I治疗甲状腺癌498例临床分析[J].临床军医杂志,2013(2):140~142. [3] Fontenot T E,Deniwar A,Bhatia P,et al.Percutaneous ethanol injection vs reoperation for locally recurrent papillary thyroid cancer:a systematic review and pooled analysis[J].Jama Otolaryngol Head Neck Surg,2015,141(6):512~518. [4] 李向阳,丁友宏,邱亮,等.分化型甲状腺癌再次手术97例临床分析[J].山东医药,2013,53(30):62~63. [5] Zheng X,Wang S,Zhu Z.Clinical analysis of reoperation for differentiated thyroid carcinoma[J].Anhui Medical Journal,2015. [6] 吴越,张鹏飞,邵渊.甲状腺癌再手术85例临床分析[J].现代肿瘤医学,2016,24(6):889~891. [7] 邵渊,白艳霞,张少强,等.复发性甲状腺癌再次手术56例临床分析[J].现代肿瘤医学,2014,22(11):2580~2582. [8] Zhu Y M,Lin C,Wang J,et al.Reoperation experience of lateral neck dissection for papillary thyroid carcinoma[J].Chinese Journal of Medicine,2016. [9] 张春霞,杨丽,王文超.手术治疗分化型甲状腺癌76例临床分析[J].现代肿瘤医学,2016,24(5):724~726. [10] Fontenot T E,Deniwar A,Bhatia P,et al.Ethanol injection vs reoperation for recurrent papillary thyroid cancer[J].Archives of Otolaryngology-Head and Neck Surgery,2015,141(6):512~518. [11] 郑鲁明,贺青卿,庄大勇,等.分化型甲状腺癌再次手术57例临床分析[J].中国现代普通外科进展,2014,17(8):598~601. [12] Chaojie Z,Shanshan L,Zhigong Z,et al.Evaluation of the clinical value of carbon nanoparticles as lymph node tracer in differentiated thyroid carcinoma requiring reoperation[J].International Journal of Clinical Oncology,2016,21(1):68. [13] 董文武,张浩,张平,等.甲状腺乳头状癌射频消融治疗后再手术5例临床分析[J].中国实用外科杂志,2015,35(6):653~655. [14] 曾世林,黎洪浩,罗定远,等.甲状腺癌再次手术的临床分析[J].中华内分泌外科杂志,2014(4):275~277. [15] 张亚冰,张彬,鄢丹桂,等.甲状腺癌中央区域再次手术并发症的临床分析[J].中华耳鼻咽喉头颈外科杂志,2017,52(4):263~266.
2017, Vol. 23 
冀公网安备13080202000677号